These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19208807)

  • 21. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
    Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG; Edwards LS; Vanden Bergh PM; Hacker NF; Sutherland RL; O'Brien PM
    Clin Cancer Res; 2004 Jul; 10(13):4427-36. PubMed ID: 15240533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
    Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB
    Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.
    Dahiya N; Becker KG; Wood WH; Zhang Y; Morin PJ
    PLoS One; 2011; 6(7):e22119. PubMed ID: 21789222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
    Uthayanan L; El-Bahrawy M
    J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Human Monoclonal Antibody for Claudin-3 Overexpressing Carcinoma Targeting.
    Yang H; Park H; Lee YJ; Choi JY; Kim T; Rajasekaran N; Lee S; Song K; Hong S; Choi JS; Shim H; Kim YD; Hwang S; Choi YL; Shin YK
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
    Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
    Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.
    Guo F; Tian J; Cui M; Fang M; Yang L
    Mol Med Rep; 2015 Jul; 12(1):753-9. PubMed ID: 25738807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
    Leong CT; Ong CK; Tay SK; Huynh H
    Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
    Merritt WM; Lin YG; Spannuth WA; Fletcher MS; Kamat AA; Han LY; Landen CN; Jennings N; De Geest K; Langley RR; Villares G; Sanguino A; Lutgendorf SK; Lopez-Berestein G; Bar-Eli MM; Sood AK
    J Natl Cancer Inst; 2008 Mar; 100(5):359-72. PubMed ID: 18314475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.
    Lokman NA; Elder AS; Ween MP; Pyragius CE; Hoffmann P; Oehler MK; Ricciardelli C
    Oncotarget; 2013 Aug; 4(8):1199-211. PubMed ID: 23945256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
    An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
    Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
    Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
    Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
    Li N; Gou JH; Xiong J; You JJ; Li ZY
    BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects.
    Seraj S; Cho YJ; Lee JW; Ahn HJ
    Biochem Pharmacol; 2020 Jan; 171():113735. PubMed ID: 31786264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
    Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.